as on January 21, 2026 at 8:40 pm IST
Day's Low
Day's High
2.48%
Downside
0.80%
Upside
52 Week's Low
52 Week's High
62.11%
Downside
19.56%
Upside
Check Zymeworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
-0.873
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.51
Industry PE ratio
-6.974594594594595
PEG Ratio
0EBITDA
-61.0M
Revenue (TTM)
134.5M
Profit Margin
-47.16%
Return On Equity TTM
-18.46%
Track how Zymeworks Inc P/E has moved over time to understand its valuation trends.
Zymeworks Inc in the last 5 years
Lowest (-17.04x)
September 30, 2025
Industry (-6.97x)
January 21, 2026
Today (-3.51x)
January 21, 2026
Highest (3.97x)
December 31, 2022
Today’s Price to Earnings Ratio: -3.51x
Compare market cap, revenue, PE, and other key metrics of Zymeworks Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | NA | -3.51 | -47.16% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
The Zymeworks Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zymeworks Inc investment value today
Current value as on today
₹1,72,793
Returns
₹72,793
(+72.79%)
Returns from Zymeworks Inc Stock
₹66,760 (+66.76%)
Dollar Returns*
₹6,033 (+6.03%)
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Zymeworks Inc. Average target price of $35.62
Get share price movements and forecasts by analysts on Zymeworks Inc.
What analysts predicted
33.1%UPSIDE
Target Price
$35.62
Current Price
$23.83
Analyzed by
14 Analysts
Target
$35.62
Zymeworks Inc target price $35.62, a slight upside of 33.1% compared to current price of $23.83. According to 14 analysts rating.
Search interest for Zymeworks Inc Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:2% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 November
Mon, 07:11 PM
-Zymeworks and Jazz Pharmaceuticals report Phase 3 trial results for Ziihera, with shares surging about 35%.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, ZYME has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 months, ZYME stock has moved up by 32.0%
Best in 3 Years
![]()
In the last 3 years, ZYME has outperformed top 5 stocks with highest market-cap in its industry
Profit Down
![]()
Netprofit is down for the last 2 quarters, 2.31M → -19.60M (in $), with an average decrease of 946.0% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 48.72M → 27.61M (in $), with an average decrease of 43.3% per quarter
| Organisation | Zymeworks Inc |
| Headquarters | 108 Patriot Drive, Middletown, DE, United States, 19709 |
| Industry | Health Technology |
| CEO | Mr. Kenneth H. Galbraith C.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Diana Papove | Senior Manager of Corporate Communications |
Dr. Lindsey Foulkes B.Sc., Ph.D. | SVP of Corporate Development & Strategy |
Ms. Laura O'Connor | Senior VP & Chief Human Resources Officer |
Dr. Jeffrey Smith M.D. | Executive VP & Chief Medical Officer |
Mr. Kenneth H. Galbraith C.A. | Chairman of the Board, CEO & President |
Mr. Scott Platshon | Acting Chief Investment Officer |
Mr. Mark Hollywood | Executive VP & Chief Operating Officer |
Dr. Paul A. Moore Ph.D. | Chief Scientific Officer |
Ms. Shrinal Inamdar | Director of Investor Relations |
Mr. Daniel Dex J.D., Ph.D. | Senior VP, Corporate Secretary & General Counsel |
Zymeworks Inc share price today is $23.83 as on . Zymeworks Inc share today touched a day high of $24.02 and a low of $23.24.
Zymeworks Inc share touched a 52 week high of $28.49 on and a 52 week low of $9.03 on . Zymeworks Inc stock price today i.e. is trending at $23.83,which is 16.36% down from its 52 week high and 163.90% up from its 52 week low.
Zymeworks Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Zymeworks Inc (ZYME) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Zymeworks Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Zymeworks Inc share’s latest price of $23.83 as on January 21, 2026 at 8:40 pm IST, you will get 0.4196 shares of Zymeworks Inc. Learn more about
fractional shares .